Wells Fargo’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-54,433
Closed -$138K 7826
2023
Q4
$138K Buy
54,433
+9,334
+21% +$21.7K ﹤0.01% 4704
2023
Q3
$108K Sell
45,099
-21,180
-32% -$46.9K ﹤0.01% 4737
2023
Q2
$153K Buy
66,279
+29,922
+82% +$84.5K ﹤0.01% 4754
2023
Q1
$92.7K Buy
36,357
+27,684
+319% +$79.3K ﹤0.01% 4843
2022
Q4
$21.8K Sell
8,673
-685
-7% -$1.91K ﹤0.01% 5221
2022
Q3
$27K Sell
9,358
-1,460
-13% -$6.15K ﹤0.01% 5259
2022
Q2
$49K Sell
10,818
-725
-6% -$4.31K ﹤0.01% 5032
2022
Q1
$93K Buy
11,543
+3
+0% +$26 ﹤0.01% 5370
2021
Q4
$134K Buy
11,540
+8,540
+285% +$102K ﹤0.01% 5485
2021
Q3
$37K Buy
+3,000
New +$33.8K ﹤0.01% 5739

Wells Fargo's SLGC Position: Q1 2024 in Review

Wells Fargo sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 54,433 shares — an estimated $138K sold.

Wells Fargo first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $153K in Q2 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Wells Fargo reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 54,433 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $138K.
  • Wells Fargo first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Wells Fargo's SomaLogic, Inc. Class A Common Stock position peaked at $153K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.